Sergio Fazio

Professor

  • 14735 Citations
  • 62 h-Index
1979 …2021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1982 2019

Filter
Review article
2019
5 Citations (Scopus)

The forgotten lipids: Triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk

Sandesara, P. B., Virani, S. S., Fazio, S. & Shapiro, M., Jan 1 2019, In : Endocrine reviews. 40, 2, p. 537-557 21 p.

Research output: Contribution to journalReview article

Triglycerides
Cardiovascular Diseases
Cholesterol
Lipids
Lipoproteins
1 Citation (Scopus)

The PCSK9 revolution: Current status, controversies, and future directions

Warden, B. A., Fazio, S. & Shapiro, M., Jan 1 2019, In : Trends in Cardiovascular Medicine.

Research output: Contribution to journalReview article

Open Access
LDL Cholesterol
Cardiovascular Diseases
Cholesterol
Hyperlipoproteinemia Type II
United States Food and Drug Administration
2018
53 Citations (Scopus)

NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis

Tsimikas, S., Fazio, S., Ferdinand, K. C., Ginsberg, H. N., Koschinsky, M. L., Marcovina, S. M., Moriarty, P. M., Rader, D. J., Remaley, A. T., Reyes-Soffer, G., Santos, R. D., Thanassoulis, G., Witztum, J. L., Danthi, S., Olive, M. & Liu, L., Jan 16 2018, In : Journal of the American College of Cardiology. 71, 2, p. 177-192 16 p.

Research output: Contribution to journalReview article

National Heart, Lung, and Blood Institute (U.S.)
Lipoprotein(a)
Aortic Valve Stenosis
Cardiovascular Diseases
Aortic Diseases
17 Citations (Scopus)

PCSK9 from basic science discoveries to clinical trials

Shapiro, M., Tavori, H. & Fazio, S., May 1 2018, In : Circulation research. 122, 10, p. 1420-1438 19 p.

Research output: Contribution to journalReview article

Clinical Trials
Cardiovascular Diseases
Drug Discovery
Lipoproteins
Therapeutics
19 Citations (Scopus)

The Evolving Future of PCSK9 Inhibitors

Rosenson, R. S., Hegele, R. A., Fazio, S. & Cannon, C. P., Jul 17 2018, In : Journal of the American College of Cardiology. 72, 3, p. 314-329 16 p.

Research output: Contribution to journalReview article

LDL Lipoproteins
Cardiovascular Diseases
Monoclonal Antibodies
Clinical Trials
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2017
4 Citations (Scopus)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease

Fazio, S. & Shapiro, M., 2017, In : F1000Research. 6, 134.

Research output: Contribution to journalReview article

Apolipoproteins B
Lipoproteins
Cardiovascular Diseases
Cholesterol
Cardiovascular Agents
10 Citations (Scopus)

Application of PCSK9 inhibitors in practice: Challenges and opportunities

Kaufman, T., Duell, P., Purnell, J., Wojcik, C., Fazio, S. & Shapiro, M., Aug 1 2017, In : Circulation Research. 121, 5, p. 499-501 3 p.

Research output: Contribution to journalReview article

Modern 1601-history
Clinical Medicine
Patient Care
Pharmacology
Proprotein Convertase 9
19 Citations (Scopus)

PCSK9 and atherosclerosis - lipids and beyond

Shapiro, M. & Fazio, S., 2017, In : Journal of Atherosclerosis and Thrombosis. 24, 5, p. 462-472 11 p.

Research output: Contribution to journalReview article

Proprotein Convertases
Subtilisin
Atherosclerosis
Lipids
Cholesterol
2016
50 Citations (Scopus)

Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering

Norata, G. D., Tavori, H., Pirillo, A., Fazio, S. & Catapano, A. L., Oct 1 2016, In : Cardiovascular Research. 112, 1, p. 429-442 14 p.

Research output: Contribution to journalReview article

Proprotein Convertases
Subtilisin
LDL Cholesterol
Hypercholesterolemia
Cardiovascular Diseases
6 Citations (Scopus)

HDL particle size and functional heterogeneity

Fazio, S. & Pamir, N., Sep 2 2016, In : Circulation Research. 119, 6, p. 704-707 4 p.

Research output: Contribution to journalReview article

Particle Size
HDL Cholesterol
2015
2 Citations (Scopus)

Is it Time to Enhance Assessment of Alcohol Intake in Patients Slated for Statin Therapy?

Kabagambe, E. K. & Fazio, S., Jan 1 2015, In : Current Nutrition Reports. 4, 1

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
alcohols
Alcohols
therapeutics
Therapeutics